Literature DB >> 8417496

The effect of prednisone on pancreatic islet autografts in dogs.

Y Zeng1, C Ricordi, J Lendoire, P B Carroll, R Alejandro, D R Bereiter, A Tzakis, T E Starzl.   

Abstract

Prednisone was shown to induce hyperglycemia in dogs submitted to total pancreatectomy and pancreatic islet autotransplantation. The hyperglycemia caused by a 10-day course of prednisone, 1 mg/kg/day, starting on the day of operation was reversible within 1 week after steroid discontinuance. Three weeks after prednisone was stopped, there was no detectable adverse effect on glucose homeostasis as judged by fasting blood sugar levels and intravenous glucose tolerance test results. Four months after transplantation, glucose disappearance was delayed in animals previously treated with the prednisone compared with those previously treated with prednisone plus insulin or control animals. This was accompanied by lower insulin values on intravenous glucose tolerance testing and suggests a long-term subtle effect on islet function. The mechanism of the steroid effect is not known. However, this model could be used to test the diabetogenicity of other immunosuppressive agents including cyclosporine, FK 506, and azathioprine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417496      PMCID: PMC2993061     

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

1.  Experimental steroid diabetes.

Authors:  D J INGLE
Journal:  Diabetes       Date:  1956 May-Jun       Impact factor: 9.461

2.  Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator.

Authors:  S P Lake; P D Bassett; A Larkins; J Revell; K Walczak; J Chamberlain; G M Rumford; N J London; P S Veitch; P R Bell
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

3.  Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus.

Authors:  G L Warnock; N M Kneteman; E Ryan; R E Seelis; A Rabinovitch; R V Rajotte
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

4.  Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.

Authors:  J L Leahy; S Bonner-Weir; G C Weir
Journal:  Diabetes       Date:  1984-07       Impact factor: 9.461

5.  Isolation of pancreatic islets from dogs. Semiautomated purification on albumin gradients.

Authors:  R Alejandro; S Strasser; P F Zucker; D H Mintz
Journal:  Transplantation       Date:  1990-08       Impact factor: 4.939

6.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

Authors:  J L Leahy; H E Cooper; D A Deal; G C Weir
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Long-term effects of glucose on insulin release and glucose oxidation by mouse pancreatic islets maintained in tissue culture.

Authors:  A Andersson
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

8.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

9.  Steroid-induced diabetes in pediatric renal transplant recipients.

Authors:  R S Fennell; J Van Deusen; W J Riley
Journal:  Int J Pediatr Nephrol       Date:  1983-06

10.  Prednisone, azathioprine, and cyclosporine A toxicity on human fetal pancreas.

Authors:  D K Leonard; A S Landry; H W Sollinger; D A Hullett
Journal:  J Surg Res       Date:  1989-06       Impact factor: 2.192

View more
  8 in total

Review 1.  Islet and stem cell transplantation for treating diabetes.

Authors:  P Serup; O D Madsen; T Mandrup-Poulsen
Journal:  BMJ       Date:  2001-01-06

2.  Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Authors:  Andrew M Posselt; Gregory L Szot; Lynda A Frassetto; Umesh Masharani; Mehdi Tavakol; Raj Amin; Joan McElroy; Marissa D Ramos; Robert K Kerlan; Lawrence Fong; Flavio Vincenti; Jeffrey A Bluestone; Peter G Stock
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

Review 3.  Engineering the vasculature for islet transplantation.

Authors:  Daniel T Bowers; Wei Song; Long-Hai Wang; Minglin Ma
Journal:  Acta Biomater       Date:  2019-05-23       Impact factor: 8.947

4.  Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

Authors:  A M Posselt; M D Bellin; M Tavakol; G L Szot; L A Frassetto; U Masharani; R K Kerlan; L Fong; F G Vincenti; B J Hering; J A Bluestone; P G Stock
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

Review 5.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

Review 6.  Islet transplantation in type I diabetes mellitus.

Authors:  Ryan M Jamiolkowski; Lucie Y Guo; Yun Rose Li; Sydney M Shaffer; Ali Naji
Journal:  Yale J Biol Med       Date:  2012-03-29

Review 7.  Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets.

Authors:  Yannan Shi; Ying-Zheng Zhao; Zhikai Jiang; Zeqing Wang; Qian Wang; Longfa Kou; Qing Yao
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

8.  Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats.

Authors:  Qingzhen Gao; Xiaoping Wang; Ruibin Zhang; Pu Wang; Yongsheng Jing; Wanjun Ren; Bin Zhu
Journal:  J Diabetes Investig       Date:  2016-01-23       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.